Periodic Reporting for period 1 - AutoStopS (GluCl as an epileptic seizure autoregulatory Gene therapeutic approach)

Around 70 Million people worldwide are affected by epilepsy (estimates for Europe 0.6-0.7% of the general population) (http://www.who.int/mediacentre/factsheets/fs999/en/; accessed 10/05/2015), of whom at least 20% (14 million people) do not respond to commonly available...